| Literature DB >> 23653651 |
J C Bewick1, M A Buchanan, A C Frosh.
Abstract
Introduction. Internal nasal valve incompetence (INVI) has been treated with various surgical methods. Large, single surgeon case series are lacking, meaning that the evidence supporting a particular technique has been deficient. We present a case series using alar batten grafts to reconstruct the internal nasal valve, all performed by the senior author. Methods. Over a 7-year period, 107 patients with nasal obstruction caused by INVI underwent alar batten grafting. Preoperative assessment included the use of nasal strips to evaluate symptom improvement. Visual analogue scale (VAS) assessment of nasal blockage (NB) and quality of life (QOL) both pre- and postoperatively were performed and analysed with the Wilcoxon signed rank test. Results. Sixty-seven patients responded to both pre- and postoperative questionnaires. Ninety-one percent reported an improvement in NB and 88% an improvement in QOL. The greatest improvement was seen at 6 months (median VAS 15 mm and 88 mm resp., with a P value of <0.05 for both). Nasal strips were used preoperatively and are a useful tool in predicting patient operative success in both NB and QOL (odds ratio 2.15 and 2.58, resp.). Conclusions. Alar batten graft insertion as a single technique is a valid technique in treating INVI and produces good outcomes.Entities:
Year: 2013 PMID: 23653651 PMCID: PMC3638702 DOI: 10.1155/2013/734795
Source DB: PubMed Journal: Int J Otolaryngol ISSN: 1687-9201
Figure 1Alar batten graft insertion. The graft can be seen superficial and cephalic to the upper lateral cartilage thereby supporting the upper lateral cartilage and preventing collapse.
Nasal blockage and quality of life VAS scores with Wilcoxon signed-rank test P values. Eleven patients completed the questionnaire at both 6 and 12 months.
| Median nasal blockage VAS score in mm (range) | Nasal blockage | Median overall quality of life VAS score in mm (range) | Quality of life | |
|---|---|---|---|---|
| Preoperatively ( | 73.5 (18–100) | 31 (3–87) | ||
| 1 week ( | 32 (5–90) | <0.005 | 78 (4–96) | <0.005 |
| 6 weeks ( | 17 (1–94) | <0.005 | 85 (3–100) | <0.005 |
| 6 months ( | 15 (0–90) | <0.005 | 88 (16–100) | <0.005 |
| 12 months ( | 19 (2–100) | <0.005 | 80 (20–100) | <0.005 |
Figure 2Median nasal breathing scores over time in months (0 = no patency, 100 = full patency) and quality of life scores over time (0 = severe impact on quality of life, 100 = no impact on quality of life).